Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2025-12-25 @ 1:27 PM
Study NCT ID:
NCT02950259
Status:
COMPLETED
Last Update Posted:
2025-12-03
First Post:
2016-10-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Sponsor:
Providence Health & Services
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-28
First Submit QC Date:
None
Study First Post Date:
2016-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-05-23
Results First Submit QC Date:
None
Results First Post Date:
2024-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED